About
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Key Metrics
as of Sep 2026Market Cap95,116 Cr
P/E25.20
Div Yield0.24 %
Book Value₹652.00
52w High₹1,717.00
52w Low₹1,035.00
Face Value₹1.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9,150.00 | 8,853.00 | 8,646.00 | 8,286.00 | 7,868.00 | 8,382.00 | 7,979.00 | 7,796.00 | 7,567.00 | 7,580.00 | 7,352.00 | 7,219.00 | 6,851.00 |
| Expenses | 7,271.00 | 7,103.00 | 6,873.00 | 6,608.00 | 6,265.00 | 6,622.00 | 6,401.00 | 6,230.00 | 5,949.00 | 5,920.00 | 5,753.00 | 5,846.00 | 5,702.00 |
| Operating Profit | 1,880.00 | 1,750.00 | 1,773.00 | 1,678.00 | 1,603.00 | 1,760.00 | 1,578.00 | 1,566.00 | 1,618.00 | 1,660.00 | 1,599.00 | 1,373.00 | 1,149.00 |
| OPM % | 21.00 | 20.00 | 21.00 | 20.00 | 20.00 | 21.00 | 20.00 | 20.00 | 21.00 | 22.00 | 22.00 | 19.00 | 17.00 |
| Other Income | 224.00 | 117.00 | 123.00 | 122.00 | 107.00 | 135.00 | 159.00 | 136.00 | 221.00 | 14.00 | 163.00 | 188.00 | 47.00 |
| Depreciation | 487.00 | 479.00 | 465.00 | 429.00 | 406.00 | 444.00 | 419.00 | 382.00 | 404.00 | 354.00 | 423.00 | 418.00 | 327.00 |
| Interest | 102.00 | 98.00 | 93.00 | 95.00 | 98.00 | 115.00 | 118.00 | 113.00 | 111.00 | 89.00 | 76.00 | 68.00 | 57.00 |
| Profit before tax | 1,515.00 | 1,291.00 | 1,339.00 | 1,276.00 | 1,207.00 | 1,335.00 | 1,200.00 | 1,207.00 | 1,324.00 | 1,230.00 | 1,262.00 | 1,076.00 | 812.00 |
| Tax % | 32.00 | 29.00 | 32.00 | 34.00 | 32.00 | 32.00 | 30.00 | 32.00 | 31.00 | 26.00 | 26.00 | 30.00 | 30.00 |
| Net Profit | 1,032.00 | 921.00 | 910.00 | 848.00 | 824.00 | 903.00 | 846.00 | 817.00 | 918.00 | 907.00 | 940.00 | 752.00 | 570.00 |
| EPS in Rs | 17.95 | 15.86 | 15.67 | 14.61 | 14.20 | 15.56 | 14.56 | 14.07 | 15.69 | 15.51 | 15.98 | 12.92 | 9.74 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 33,653.00 | 31,724.00 | 29,002.00 | 24,855.00 | 23,455.00 | 24,775.00 | 23,099.00 | 19,564.00 | 16,463.00 | 14,910.00 | 13,772.00 | 12,103.00 |
| Expenses | 26,783.00 | 25,164.00 | 23,176.00 | 21,148.00 | 19,060.00 | 19,497.00 | 18,249.00 | 15,612.00 | 12,691.00 | 11,469.00 | 10,579.00 | 9,524.00 |
| Operating Profit | 6,870.00 | 6,560.00 | 5,826.00 | 3,707.00 | 4,396.00 | 5,278.00 | 4,849.00 | 3,952.00 | 3,772.00 | 3,441.00 | 3,193.00 | 2,579.00 |
| OPM % | 20.00 | 21.00 | 20.00 | 15.00 | 19.00 | 21.00 | 21.00 | 20.00 | 23.00 | 23.00 | 23.00 | 21.00 |
| Other Income | 404.00 | 613.00 | 366.00 | 291.00 | 152.00 | 3,195.00 | 166.00 | 70.00 | 105.00 | 115.00 | 200.00 | 81.00 |
| Interest | 384.00 | 457.00 | 290.00 | 140.00 | 49.00 | 74.00 | 305.00 | 263.00 | 78.00 | 67.00 | 257.00 | 160.00 |
| Depreciation | 1,778.00 | 1,649.00 | 1,522.00 | 1,245.00 | 1,127.00 | 1,055.00 | 967.00 | 668.00 | 558.00 | 428.00 | 392.00 | 333.00 |
| Profit before tax | 5,112.00 | 5,066.00 | 4,380.00 | 2,612.00 | 3,373.00 | 7,344.00 | 3,743.00 | 3,091.00 | 3,241.00 | 3,061.00 | 2,744.00 | 2,168.00 |
| Tax % | 31.00 | 31.00 | 28.00 | 26.00 | 22.00 | 27.00 | 24.00 | 24.00 | 25.00 | 25.00 | 26.00 | 28.00 |
| Net Profit | 3,503.00 | 3,484.00 | 3,169.00 | 1,928.00 | 2,647.00 | 5,334.00 | 2,844.00 | 2,364.00 | 2,423.00 | 2,301.00 | 2,024.00 | 1,571.00 |
| EPS in Rs | 60.34 | 60.02 | 54.15 | 32.90 | 45.20 | 91.05 | 48.56 | 40.36 | 41.36 | 39.29 | 34.61 | 26.98 |
| Dividend Payout % | 7.00 | 0.00 | 8.00 | 23.00 | 20.00 | 4.00 | 6.00 | 6.00 | 6.00 | 6.00 | 7.00 | 8.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 58.00 | 58.00 | 59.00 | 59.00 | 59.00 | 59.00 | 59.00 | 59.00 | 59.00 | 59.00 | 59.00 | 29.00 |
| Reserves | 37,833.00 | 32,595.00 | 29,784.00 | 26,781.00 | 24,517.00 | 21,871.00 | 16,766.00 | 13,832.00 | 11,622.00 | 9,313.00 | 7,229.00 | 5,127.00 |
| Borrowings | 8,073.00 | 8,263.00 | 6,648.00 | 5,286.00 | 2,851.00 | 5,339.00 | 5,826.00 | 6,967.00 | 4,770.00 | 3,364.00 | 5,041.00 | 4,451.00 |
| Other Liabilities | 12,232.00 | 8,566.00 | 8,227.00 | 7,379.00 | 6,211.00 | 6,147.00 | 6,113.00 | 5,414.00 | 4,492.00 | 3,464.00 | 3,568.00 | 3,303.00 |
| Total Liabilities | 58,196.00 | 49,482.00 | 44,717.00 | 39,505.00 | 33,638.00 | 33,416.00 | 28,765.00 | 26,271.00 | 20,942.00 | 16,200.00 | 15,896.00 | 12,910.00 |
| Fixed Assets | 17,407.00 | 14,794.00 | 14,493.00 | 11,024.00 | 10,532.00 | 9,374.00 | 9,396.00 | 8,475.00 | 6,521.00 | 4,834.00 | 4,180.00 | 3,706.00 |
| CWIP | 5,214.00 | 4,900.00 | 3,869.00 | 5,390.00 | 3,747.00 | 3,062.00 | 1,986.00 | 1,668.00 | 1,583.00 | 1,458.00 | 848.00 | 420.00 |
| Investments | 1,051.00 | 252.00 | 372.00 | 543.00 | 997.00 | 591.00 | 555.00 | 360.00 | 312.00 | 246.00 | 123.00 | 20.00 |
| Other Assets | 34,525.00 | 29,536.00 | 25,983.00 | 22,549.00 | 18,362.00 | 20,390.00 | 16,827.00 | 15,768.00 | 12,527.00 | 9,662.00 | 10,745.00 | 8,765.00 |
| Total Assets | 58,196.00 | 49,482.00 | 44,717.00 | 39,505.00 | 33,638.00 | 33,416.00 | 28,765.00 | 26,271.00 | 20,942.00 | 16,200.00 | 15,896.00 | 12,910.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 5,526.00 | 3,925.00 | 2,435.00 | 2,387.00 | 5,016.00 | 3,329.00 | 4,381.00 | 1,651.00 | 1,955.00 | 3,279.00 | 1,420.00 | 1,237.00 |
| Cash from Investing Activity | -2,630.00 | -1,866.00 | -4,242.00 | -3,971.00 | -3,211.00 | 597.00 | -1,563.00 | -2,904.00 | -1,927.00 | -1,787.00 | -1,446.00 | -1,017.00 |
| Cash from Financing Activity | -1,269.00 | 120.00 | 800.00 | 1,814.00 | -2,969.00 | -1,365.00 | -1,947.00 | 1,919.00 | 864.00 | -1,915.00 | 365.00 | 93.00 |
| Net Cash Flow | 1,628.00 | 2,178.00 | -1,007.00 | 230.00 | -1,164.00 | 2,561.00 | 871.00 | 666.00 | 892.00 | -424.00 | 340.00 | 313.00 |
| Free Cash Flow | 2,468.00 | 1,408.00 | -1,067.00 | -323.00 | 2,693.00 | 1,503.00 | 2,969.00 | 114.00 | 714.00 | 1,594.00 | -146.00 | 491.00 |
| CFO/OP % | 107.00 | 86.00 | 72.00 | 84.00 | 143.00 | 87.00 | 106.00 | 61.00 | 70.00 | 118.00 | 67.00 | 67.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 77.00 | 66.00 | 61.00 | 66.00 | 62.00 | 52.00 | 68.00 | 64.00 | 68.00 | 68.00 | 122.00 | 107.00 |
| Inventory Days | 326.00 | 295.00 | 284.00 | 275.00 | 272.00 | 333.00 | 289.00 | 304.00 | 317.00 | 246.00 | 240.00 | 239.00 |
| Days Payable | 151.00 | 117.00 | 129.00 | 125.00 | 97.00 | 103.00 | 97.00 | 107.00 | 128.00 | 122.00 | 146.00 | 136.00 |
| Cash Conversion Cycle | 252.00 | 244.00 | 216.00 | 216.00 | 237.00 | 282.00 | 260.00 | 260.00 | 257.00 | 191.00 | 217.00 | 210.00 |
| Working Capital Days | 44.00 | 49.00 | 66.00 | 55.00 | 84.00 | 52.00 | 35.00 | 25.00 | 50.00 | 51.00 | 44.00 | 50.00 |
| ROCE % | 13.00 | 14.00 | 14.00 | 9.00 | 13.00 | 18.00 | 19.00 | 18.00 | 23.00 | 25.00 | 27.00 | 27.00 |
Corporate Actions
50 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Other | 17 Apr 2026 | 17 Apr 2026 | — | — | Buy Back of Shares |
| Other | 17 Apr 2026 | 17 Apr 2026 | — | — | Buy Back |
| Dividend | 08 Aug 2025 | 08 Aug 2025 | — | 4.00 | |
| Other | 26 Aug 2024 | — | — | — | Annual General Meeting |
| Other | 30 Jul 2024 | 30 Jul 2024 | — | — | Buy Back of Shares |
| Other | 30 Jul 2024 | 30 Jul 2024 | — | — | Buy Back |
| Dividend | 20 Feb 2024 | 20 Feb 2024 | — | 1.50 | |
| Dividend | 20 Nov 2023 | 20 Nov 2023 | — | 3.00 | |
| Other | 22 Aug 2023 | — | — | — | Annual General Meeting |
| Dividend | 17 Feb 2023 | 17 Feb 2023 | — | 3.00 | |
| Other | 27 Jul 2022 | — | — | — | Annual General Meeting |
| Dividend | 06 Jun 2022 | 07 Jun 2022 | — | 4.50 | |
| Dividend | 18 Feb 2022 | 21 Feb 2022 | — | 1.50 | |
| Dividend | 17 Nov 2021 | 18 Nov 2021 | — | 1.50 | |
| Dividend | 27 Aug 2021 | 30 Aug 2021 | — | 1.50 | |
| Other | 20 Aug 2021 | — | — | — | Annual General Meeting |
| Dividend | 22 Feb 2021 | 23 Feb 2021 | — | 1.50 | |
| Dividend | 23 Nov 2020 | 24 Nov 2020 | — | 1.25 | |
| Dividend | 21 Aug 2020 | — | — | 1.25 | |
| Dividend | 17 Feb 2020 | 18 Feb 2020 | — | 1.75 | |
| Dividend | 21 Nov 2019 | 23 Nov 2019 | — | 1.25 | |
| Other | 21 Aug 2019 | — | — | — | Annual General Meeting |
| Dividend | 15 Feb 2019 | 19 Feb 2019 | — | 1.25 | |
| Dividend | 20 Nov 2018 | 22 Nov 2018 | — | 1.25 | |
| Other | 21 Aug 2018 | — | — | — | Annual General Meeting |
| Dividend | 20 Feb 2018 | 21 Feb 2018 | — | 1.00 | |
| Dividend | 21 Nov 2017 | 22 Nov 2017 | — | 1.50 | |
| Other | 23 Aug 2017 | — | — | — | Annual General Meeting |
| Dividend | 08 Jun 2017 | 09 Jun 2017 | — | 1.25 | |
| Dividend | 24 Nov 2016 | 25 Nov 2016 | — | 1.25 | |
| Other | 12 Aug 2016 | — | — | — | Annual General Meeting |
| Dividend | 09 Jun 2016 | 10 Jun 2016 | — | 0.70 | |
| Dividend | 18 Feb 2016 | 22 Feb 2016 | — | 0.70 | |
| Dividend | 19 Nov 2015 | 20 Nov 2015 | — | 0.60 | |
| Dividend | 21 Aug 2015 | — | — | 0.50 | |
| Bonus | 20 Jul 2015 | 21 Jul 2015 | 1:1 | — | |
| Dividend | 08 Jun 2015 | 09 Jun 2015 | — | 1.00 | |
| Dividend | 16 Feb 2015 | 18 Feb 2015 | — | 2.00 | |
| Dividend | 13 Aug 2014 | — | — | 1.50 | |
| Dividend | 11 Jun 2014 | 12 Jun 2014 | — | 1.75 | |
| Dividend | 19 Nov 2013 | 20 Nov 2013 | — | 1.25 | |
| Dividend | 30 Jul 2013 | — | — | 0.50 | |
| Dividend | 18 Feb 2013 | 20 Feb 2013 | — | 1.00 | |
| Dividend | 30 Jul 2012 | — | — | 1.00 | |
| Dividend | 20 Jul 2011 | — | — | 1.00 | |
| Split | 10 Feb 2011 | 11 Feb 2011 | 5:1 | — | |
| Dividend | 11 Nov 2010 | 12 Nov 2010 | — | 5.00 | |
| Dividend | 13 Sep 2010 | — | — | 2.00 | |
| Dividend | 05 Feb 2010 | 08 Feb 2010 | — | 3.00 | |
| Dividend | 16 Dec 2009 | — | — | 1.50 |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update10 Jun from fitch
-
Rating update11 Mar 2025 from fitch
-
Rating update20 Dec 2023 from fitch
-
Rating update20 Oct 2022 from fitch
-
Rating update6 Aug 2021 from fitch
-
Rating update4 Aug 2021 from fitch
Conference Calls
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript